Enhance Efficiency and Decision Making During Research and Development

DIA/FDA: Revitalizing Productivity in Drug Development October 23-24 | Bethesda, MD Review the status quo of the pharmaceutical industry and explore the initiatives that champion the continued revitalization of R&D productivity in drug development. This two-day conference will provide a forum for industry, regulators, and academia to come together to discuss challenges and opportunities, share visions, experiences, and lessons learned, as well as successes and failures in the challenging journey of drug development. Hotel Discount ends October 1. Hurry, Space is Limited!   Program Overview | Register Today Stay Connected with DIA Formulate Innovative Thinking for Revitalizing R&D Productivity Keynote Speakers: Keynote Address I - Revitalizing R&D: What Could We Be Doing Differently? Robert J. Temple, MD Deputy Center Director for Clinical Science CDER, FDA Keynote Address II - An Overview of the Future for Drug Development Under the New Imperatives Delivered by Both Commercial and Regulatory Pressures Stephen A. Arlington, PhD Partner, Global Pharmaceutical and Life Sciences Advisory Services Leader PricewaterhouseCoopers LLP Keynote Address III - How Do We Revitalize R&D in New Drug Development? Frank W. Rockhold, PhD Senior Vice President, Global Clinical Safety and Pharmacovigilance GlaxoSmithKline Keynote Address IV - Collaborative Approaches to Advancing Clinical Development Charles G. Beever, MBA Vice President Booz and Company Get Perspective from these CDER, FDA Speakers: Ni Khin, MD Medical Officer, Division of Scientific Investigations Sumathi Nambiar, MD, MPH Deputy Director for Safety, Division of Anti-Infective Products Robert T. O'Neill, PhD Senior Statistical Advisor, Office of Translational Sciences H.M. James Hung, PhD Division Director, Office of Translational Science Freda W. Cooner, PhD Mathematical Statistician, Office of Translational Science Rajeshwari Sridhara, PhD Director, Division of Biometric V, OB/OTS Geoffrey Kim Medical Officer, Division of Oncology Products Office of Hematology and Oncology Leslie Ball, MD Acting Director, Office of Scientific Investigations Shakuntala M. Malik, MD Medical Office, Division Office of Hematology Oncology Drug products (OHOP) Peiling Yang, PhD Math Statistician Team Lead, OTS Sue-Jane Wang, PhD, MA, MS Associate Director, Adaptive Design and Pharmacogenomics, OB, OTS In collaboration with

DIA Worldwide Headquarters
800 Enterprise Road, Suite 200
Horsham, Pennsylvania 19044-3595
T. +1.215.442.6100
F. +1.215.442.6199
email: dia@diahome.org